How golden is the gold standard of neuropathology in dementia?
Philip Scheltens, Kenneth J. Rockwood
Amsterdam UMC Location Vrije Universiteit Amsterdam Dalhousie University
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Current Alzheimer's disease (AD) criteria state that a definite diagnosis can only be made by postmortem examination. The neuropathological confirmation is often referred to as the "gold standard." In this article, we review what constitutes a gold standard and how the neuropathological examination of AD lives up to that standard. We conclude that there is no evidence for this notion because results between different laboratories differ to an important extent, especially when the clinical picture is in doubt, for example, when the dementia is mild. As an alternative, we propose to abandon thinking in standards and value neuropathology as any other biomarker, and to strive to use and integrate multiple sources of information to make the diagnosis of AD in all its complexity.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Dementia and Cognitive Impairment Research
Alzheimer's disease research and treatments · Neuroinflammation and Neurodegeneration Mechanisms
参考文献 20
此处列出前 3 条
引用本文 93
按被引量排序,此处列出前 3 条